160 related articles for article (PubMed ID: 34899923)
1. Hereditary Tyrosinemia Type 1 in Jordan: A Retrospective Study.
Megdadi NA; Almigdad AK; Alakil MO; Alqiam SM; Rababah SG; Dwiari MA
Int J Pediatr; 2021; 2021():3327277. PubMed ID: 34899923
[TBL] [Abstract][Full Text] [Related]
2. Phenotype, genotype, and outcome of 25 Palestinian patients with hereditary tyrosinemia type 1.
Dweikat I; Qawasmi N; Najeeb A; Radwan M
Metabol Open; 2021 Mar; 9():100083. PubMed ID: 33598652
[TBL] [Abstract][Full Text] [Related]
3. Initial presentation, management and follow-up data of 33 treated patients with hereditary tyrosinemia type 1 in the absence of newborn screening.
Hajji H; Imbard A; Spraul A; Taibi L; Barbier V; Habes D; Brassier A; Arnoux JB; Bouchereau J; Pichard S; Sissaoui S; Lacaille F; Girard M; Debray D; de Lonlay P; Schiff M
Mol Genet Metab Rep; 2022 Dec; 33():100933. PubMed ID: 36393896
[TBL] [Abstract][Full Text] [Related]
4. Hereditary Tyrosinemia Type 1 in Turkey.
Aktuglu-Zeybek AC; Kiykim E; Cansever MS
Adv Exp Med Biol; 2017; 959():157-172. PubMed ID: 28755194
[TBL] [Abstract][Full Text] [Related]
5. Clinical and para clinical findings in the children with tyrosinemia referring for liver transplantation.
Dehghani SM; Haghighat M; Imanieh MH; Karamnejad H; Malekpour A
Int J Prev Med; 2013 Dec; 4(12):1380-5. PubMed ID: 24498493
[TBL] [Abstract][Full Text] [Related]
6. Hereditary tyrosinemia type 1 in Turkey: twenty year single-center experience.
Zeybek AC; Kiykim E; Soyucen E; Cansever S; Altay S; Zubarioglu T; Erkan T; Aydin A
Pediatr Int; 2015 Apr; 57(2):281-9. PubMed ID: 25223216
[TBL] [Abstract][Full Text] [Related]
7. A case report of two siblings with hypertyrosinemia type 1 presenting with hepatic disease with different onset time and severity.
Kawabata K; Kido J; Yoshida T; Matsumoto S; Nakamura K
Mol Genet Metab Rep; 2022 Sep; 32():100892. PubMed ID: 35800472
[TBL] [Abstract][Full Text] [Related]
8. Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Québec.
Larochelle J; Alvarez F; Bussières JF; Chevalier I; Dallaire L; Dubois J; Faucher F; Fenyves D; Goodyer P; Grenier A; Holme E; Laframboise R; Lambert M; Lindstedt S; Maranda B; Melançon S; Merouani A; Mitchell J; Parizeault G; Pelletier L; Phan V; Rinaldo P; Scott CR; Scriver C; Mitchell GA
Mol Genet Metab; 2012 Sep; 107(1-2):49-54. PubMed ID: 22885033
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of nitisinone for the treatment of hereditary tyrosinemia type-1 (HT-1).
Das AM
Appl Clin Genet; 2017; 10():43-48. PubMed ID: 28769581
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and Therapeutic Challenges of Hereditary Tyrosinemia Type 1 in Lebanon: A 12-Year Retrospective Review.
Daou KN; Barhoumi A; Bassyouni A; Karam PE
Front Pediatr; 2021; 9():698577. PubMed ID: 34422723
[No Abstract] [Full Text] [Related]
11. Clinical and genetic characteristics of two patients with tyrosinemia type 1 in Slovenia - A novel fumarylacetoacetate hydrolase (
Sikonja J; Brecelj J; Zerjav Tansek M; Repic Lampret B; Drole Torkar A; Klemencic S; Lipovec N; Stefanova Kralj V; Bertok S; Kovac J; Faganel Kotnik B; Tesarova M; Remec ZI; Debeljak M; Battelino T; Groselj U
Mol Genet Metab Rep; 2022 Mar; 30():100836. PubMed ID: 35242570
[TBL] [Abstract][Full Text] [Related]
12. Long-term cognitive functioning in individuals with tyrosinemia type 1 treated with nitisinone and protein-restricted diet.
García MI; de la Parra A; Arias C; Arredondo M; Cabello JF
Mol Genet Metab Rep; 2017 Jun; 11():12-16. PubMed ID: 28377889
[TBL] [Abstract][Full Text] [Related]
13. Tyrosinemia type I: clinical and biochemical analysis of patients in Mexico.
Fernández-Lainez C; Ibarra-González I; Belmont-Martínez L; Monroy-Santoyo S; Guillén-López S; Vela-Amieva M
Ann Hepatol; 2014; 13(2):265-72. PubMed ID: 24552869
[TBL] [Abstract][Full Text] [Related]
14. Type 1 tyrosinemia in Finland: a nationwide study.
Äärelä L; Hiltunen P; Soini T; Vuorela N; Huhtala H; Nevalainen PI; Heikinheimo M; Kivelä L; Kurppa K
Orphanet J Rare Dis; 2020 Oct; 15(1):281. PubMed ID: 33046095
[TBL] [Abstract][Full Text] [Related]
15. Tyrosinemia type 1 in Spain: mutational analysis, treatment and long-term outcome.
Couce ML; Dalmau J; del Toro M; Pintos-Morell G; Aldámiz-Echevarría L;
Pediatr Int; 2011 Dec; 53(6):985-9. PubMed ID: 21752152
[TBL] [Abstract][Full Text] [Related]
16. Hereditary tyrosinemia type 1 from a single center in Egypt: clinical study of 22 cases.
El-Karaksy H; Fahmy M; El-Raziky M; El-Koofy N; El-Sayed R; Rashed MS; El-Kiki H; El-Hennawy A; Mohsen N
World J Pediatr; 2011 Aug; 7(3):224-31. PubMed ID: 21633861
[TBL] [Abstract][Full Text] [Related]
17. Outcome of children with hereditary tyrosinaemia following newborn screening.
McKiernan PJ; Preece MA; Chakrapani A
Arch Dis Child; 2015 Aug; 100(8):738-41. PubMed ID: 25564536
[TBL] [Abstract][Full Text] [Related]
18. The outcome of seven patients with hereditary tyrosinemia type 1.
Gokay S; Ustkoyuncu PS; Kardas F; Kendirci M
J Pediatr Endocrinol Metab; 2016 Oct; 29(10):1151-1157. PubMed ID: 27682708
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and Clinical Aspects of Hereditary Tyrosinemia Type 1.
Morrow G; Tanguay RM
Adv Exp Med Biol; 2017; 959():9-21. PubMed ID: 28755181
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
